|
Glioblastoma
|
|
|
|
M.
Altinbas, M. Ozkan, O. Er, H. Everest, S. H. Coskun, A. Menku, Y.
Cihan, B. Kaplan
Adjuvant
radiotherapy and fotemustine in treatment of anaplastic astrocytoma and
glioblastoma multiforme patients
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 459
|
|
Fazeny-Dorner
B, Veitl M, Wenzel C, Rossler K, Ungersbock K, Dieckmann K, Piribauer
M, Hainfellner J, Marosi C
Survival
with dacarbazine and fotemustine in newly diagnosed glioblastoma
multiforme
Br J Cancer 2003 Feb 24;88(4):496-501
|
|
Ilc K, Ferrero JM, Fischel JL, Formento P, Bryce R,
Etienne MC, Milano G
Cytotoxic
effects of two gamma linoleic salts (lithium gammalinolenate or meglumine
gammalinolenate) alone or associated with a nitrosourea: an experimental study
on human glioblastoma cell lines
Anticancer Drugs
1999 Apr;10(4):413-7
|
|
|
Antonio Silvani, Elena Lamperti, Paola Gaviani,
Marica Eoli, Anna Fiumani, Andrea Salmaggi, Chiara Falcone,
Graziella Filippini, Andrea Botturi and Amerigo Boiardi
Salvage chemotherapy with procarbazine and fotemustine combination in the
treatment of temozolomide treated recurrent glioblastoma patients
Journal of Neuro-Oncology, Epub June 19, 2007, DOI:
10.1007/s11060-007-9427-y
Abstract |
Reprint
|
DBLinks | BL 7:4
|
|
|
Gliomas
|
|
|
|
Boiardi A, Silvani A, Ciusani
E, Watson A, Margison G, Berger E, Lucas C, Giroux B
Fotemustine combined with procarbazine in
recurrent malignant gliomas: a phase I study with evaluation of
lymphocyte 06-alkylguanine-DNA alkyltransferase activity
J Neurooncol 2001 Apr;52(2):149-56
|
|
Bourg
V, Lebrun C, Chichmanian RM, Thomas P, Frenay M
Nitroso-urea-cisplatin-based
chemotherapy associated with valproate: increase of haematologic toxicity
Ann Oncol 2001 Feb;12(2):217-9
|
|
Gander
M, Leyvraz S, Decosterd L, Bonfanti M, Marzolini C, Shen F, Lienard D,
Perey L, Colella G, Biollaz J, Lejeune F, Yarosh D, Belanich M, D'Incalci
M.
Sequential administration of temozolomide and
fotemustine: depletion of O6-alkyl guanine-DNA transferase in blood
lymphocytes and in tumours
Ann Oncol 1999 Jul;10(7):831-8
|
|
Marzolini
C, Decosterd LA, Shen F, Gander M, Leyvraz S, Bauer J, Buclin T,
Biollaz J, Lejeune F.
Pharmacokinetics
of temozolomide in association with fotemustine in malignant melanoma and
malignant glioma patients: comparison of oral, intravenous, and hepatic
intra-arterial administration
Cancer
Chemother Pharmacol 1998;42(6):433-40
|
|